SETX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.318800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.266200E-01
Normal-vs-Stage2
4.352000E-01
Normal-vs-Stage3
2.754000E-01
Normal-vs-Stage4
4.963600E-01
Stage1-vs-Stage2
8.825400E-01
Stage1-vs-Stage3
7.123600E-02
Stage1-vs-Stage4
3.338800E-01
Stage2-vs-Stage3
2.595300E-03
Stage2-vs-Stage4
3.209200E-01
Stage3-vs-Stage4
3.915800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.226600E-01
Normal-vs-AfricanAmerican
4.649400E-01
Normal-vs-Asian
4.157200E-01
Caucasian-vs-AfricanAmerican
1.433430E-01
Caucasian-vs-Asian
8.366400E-01
AfricanAmerican-vs-Asian
3.028800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.249600E-01
Normal-vs-Female
4.422000E-01
Male-vs-Female
6.332000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.105200E-01
Normal-vs-Age(41-60Yrs)
5.277000E-01
Normal-vs-Age(61-80Yrs)
3.981200E-01
Normal-vs-Age(81-100Yrs)
3.675400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.457600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.332800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.068400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.303400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.584500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.902800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.797200E-01
Normal-vs-Daily Drinker
3.585400E-01
Normal-vs-Weekly Drinker
4.001000E-01
Normal-vs-Occasional Drinker
4.553600E-01
Normal-vs-Social Drinker
5.394400E-01
Non Drinker-vs-Daily Drinker
6.876000E-01
Non Drinker-vs-Weekly Drinker
7.830800E-01
Non Drinker-vs-Occasional Drinker
3.197200E-01
Non Drinker-vs-Social Drinker
6.788000E-02
Daily Drinker-vs-Weekly Drinker
4.893600E-01
Daily Drinker-vs-Occasional Drinker
1.848170E-01
Daily Drinker-vs-Social Drinker
2.177700E-02
Weekly Drinker-vs-Occasional Drinker
5.404400E-01
Weekly Drinker-vs-Social Drinker
1.730230E-01
Occasional Drinker-vs-Social Drinker
4.504000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.183400E-01
Normal-vs-Grade 2
6.331900E-02
Normal-vs-Grade 3
3.896000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.853400E-01
Grade 1-vs-Grade 3
7.408400E-01
Grade 1-vs-Grade 4
2.183400E-01
Grade 2-vs-Grade 3
7.503400E-01
Grade 2-vs-Grade 4
6.331900E-02
Grade 3-vs-Grade 4
3.896000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.156800E-01
Normal-vs-NonDiabetic
4.073000E-01
Diabetic-vs-NonDiabetic
8.568800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.952200E-01
Normal-vs-NoPancreatitis
4.192000E-01
Pancreatitis-vs-NoPancreatitis
6.872000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.389600E-01
Normal-vs-N1
4.324200E-01
N0-vs-N1
8.910000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.125400E-01
Normal-vs-TP53-NonMutant
4.630200E-01
TP53-Mutant-vs-TP53-NonMutant
3.549400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
